USD
+$0.00
(+0.00%
)At Close (As of Sep 16, 2025)
$3.11B
Market Cap
14.85
P/E Ratio
4.24
EPS
$90.04
52 Week High
$61.94
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $634M |
Total Revenue | $1.1B |
Cost Of Revenue | $503M |
Costof Goods And Services Sold | $503M |
Operating Income | $337M |
Selling General And Administrative | $108M |
Research And Development | - |
Operating Expenses | $298M |
Investment Income Net | - |
Net Interest Income | -$48M |
Interest Income | $48M |
Interest Expense | $48M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $30M |
Income Before Tax | $284M |
Income Tax Expense | $70M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $215M |
Comprehensive Income Net Of Tax | - |
Ebit | $332M |
Ebitda | $362M |
Net Income | $215M |
Field | Value (USD) |
---|---|
Total Assets | $3.4B |
Total Current Assets | $448M |
Cash And Cash Equivalents At Carrying Value | $98M |
Cash And Short Term Investments | $98M |
Inventory | $148M |
Current Net Receivables | $194M |
Total Non Current Assets | $3B |
Property Plant Equipment | $128M |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $2.3B |
Intangible Assets Excluding Goodwill | $2.3B |
Goodwill | $527M |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $8.4M |
Other Non Current Assets | - |
Total Liabilities | $1.6B |
Total Current Liabilities | $107M |
Current Accounts Payable | $19M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $8.5M |
Total Non Current Liabilities | $1.5B |
Capital Lease Obligations | $52M |
Long Term Debt | $992M |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $1B |
Other Current Liabilities | $78M |
Other Non Current Liabilities | $5.4M |
Total Shareholder Equity | $1.8B |
Treasury Stock | - |
Retained Earnings | $1.6B |
Common Stock | $560K |
Common Stock Shares Outstanding | $50M |
Field | Value (USD) |
---|---|
Operating Cashflow | $252M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $30M |
Capital Expenditures | $8.2M |
Change In Receivables | - |
Change In Inventory | -$9.3M |
Profit Loss | - |
Cashflow From Investment | -$17M |
Cashflow From Financing | -$182M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | -$52M |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | $215M |
Field | Value (USD) |
---|---|
Gross Profit | $634M |
Total Revenue | $1.1B |
Cost Of Revenue | $503M |
Costof Goods And Services Sold | $503M |
Operating Income | $337M |
Selling General And Administrative | $108M |
Research And Development | - |
Operating Expenses | $298M |
Investment Income Net | - |
Net Interest Income | -$48M |
Interest Income | $48M |
Interest Expense | $48M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $30M |
Income Before Tax | $284M |
Income Tax Expense | $70M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $215M |
Comprehensive Income Net Of Tax | - |
Ebit | $332M |
Ebitda | $362M |
Net Income | $215M |
Sector: HEALTHCARE
Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC
Prestige Consumer Healthcare Inc., develops, manufactures, markets, distributes and sells over-the-counter (OTC) healthcare products in the United States and internationally. The company is headquartered in Tarrytown, New York.